DelSiTech is excited to announce our participation in the annual Drug Delivery & Formulation (DDF) Summit, to be held virtually on March 15-17th, 2021.
The DDF summit brings together formulation specialists, leading associated technologies, and pharmaceutical industry innovators to share insights for improving deliverability, continuous manufacturing, developing solutions for patient compliance, solutions to challenging routes of administration, controlled release technologies and much more, in the context of both small molecules and biological entities.
DelSiTech, as a leading developer of long-acting controlled release formulations for both small molecules and biological entities, across both parenteral and topical routes of administration, is pleased to be presenting at the event. Dr. Frederic Dargelas, Director, Head of Business Development and Alliance Management at DelSiTech will present on “Parenteral Delivery of Therapeutic Proteins and Peptides using Biodegradable Silica Matrix“. The session will be held at 12:25-13.00pm (CET) as part of the “Solutions Spotlight – Biologics” and we encourage you to join in to learn more about how large biological entities can be delivered over a sustained period utilizing Silica Matrix.